| Reporter | TradeFlow | ProductCode | Product Description | Year | Partner | Trade Value 1000USD | Quantity | Quantity Unit |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | World | 19,801.96 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | United States | 17,575.76 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Germany | 707.00 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Australia | 540.44 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Canada | 384.80 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Philippines | 184.46 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Japan | 113.35 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Korea, Rep. | 106.23 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Singapore | 68.35 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Poland | 46.65 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Other Asia, nes | 32.86 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | China | 22.08 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | United Kingdom | 10.21 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | France | 5.04 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Hong Kong, China | 2.39 | | |
| New Zealand | Export | 300190 | Glands; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | 2021 | Sweden | 2.36 | | |
